Share on StockTwits

Delcath Systems (NASDAQ:DCTH) posted its quarterly earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $0.07, Stock Ratings News reports. The company had revenue of $0.31 million for the quarter, compared to the consensus estimate of $0.20 million. The company’s revenue for the quarter was down 18.4% on a year-over-year basis.

Delcath Systems (NASDAQ:DCTH) traded down 4.95% during mid-day trading on Wednesday, hitting $3.07. 269,047 shares of the company’s stock traded hands. Delcath Systems has a 1-year low of $3.01 and a 1-year high of $10.56. The stock has a 50-day moving average of $4.23 and a 200-day moving average of $4.73. The company’s market cap is $25.7 million.

On a related note, analysts at Zacks upgraded shares of Delcath Systems from a “neutral” rating to an “outperform” rating in a research note on Tuesday, March 25th. They now have a $0.40 price target on the stock.

Delcath Systems, Inc (NASDAQ:DCTH) is a development-stage company that has developed a system designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.